Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeanette Scheible"'
Autor:
Alexander Kleger, Pierre-Olivier Frappart, Thomas Seufferlein, Peter Möller, Hans A. Kestler, Sebastian Wiese, Volker Rasche, Konstantin M.J. Sparrer, Ewa K. Kaminska, Axel Fürstberger, Li Hao, Ninel Azoitei, Thomas J. Ettrich, André Lechel, Caterina Prelli Bozzo, Jeanette Scheible, Karolin Walter, Lukas Perkhofer, Elodie Roger, Stephanie E. Weissinger, Heike Wiese, Johann Gout, Frank Arnold
Pancreatic ductal adenocarcinoma (PDAC) still presents with a dismal prognosis despite intense research. Better understanding of cellular homeostasis could identify druggable targets to improve therapy. Here we propose RAD50-interacting protein 1 (RI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a81c0c354220e7de74d24c2ff7f54301
https://doi.org/10.1158/0008-5472.c.6513184.v1
https://doi.org/10.1158/0008-5472.c.6513184.v1
Autor:
Alexander Kleger, Pierre-Olivier Frappart, Thomas Seufferlein, Peter Möller, Hans A. Kestler, Sebastian Wiese, Volker Rasche, Konstantin M.J. Sparrer, Ewa K. Kaminska, Axel Fürstberger, Li Hao, Ninel Azoitei, Thomas J. Ettrich, André Lechel, Caterina Prelli Bozzo, Jeanette Scheible, Karolin Walter, Lukas Perkhofer, Elodie Roger, Stephanie E. Weissinger, Heike Wiese, Johann Gout, Frank Arnold
Contains a more detailed method section as well as all additional supplementary figures S1 to S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a3053d93096593f057df6b3f3dc3cf5
https://doi.org/10.1158/0008-5472.22428880.v1
https://doi.org/10.1158/0008-5472.22428880.v1
Autor:
Lukas Perkhofer, Johannes R. Lemke, Marko Kornmann, Tfe Barth, J. Kraus, Amtu Kestler, Thomas Seufferlein, Hans A. Kestler, Alexander Kleger, Elodie Roger, Thomas J. Ettrich, Jeanette Scheible, L Schütte, Martin Müller, Alica K Beutel, Johann Gout
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2539, p 2539 (2021)
Volume 13
Issue 11
Cancers, Vol 13, Iss 2539, p 2539 (2021)
Volume 13
Issue 11
Real-time isolation, propagation, and pharmacotyping of patient-derived pancreatic cancer organoids (PDOs) may enable treatment response prediction and personalization of pancreatic cancer (PC) therapy. In our methodology, PDOs are isolated from 54 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040d92b47c9fe3b37d38c24aafa3f757
Autor:
Stephanie E. Weissinger, Elodie Roger, Konstantin M. J. Sparrer, Axel Fuerstberger, Frank Arnold, Lukas Perkhofer, Hans A. Kestler, Alexander Kleger, Heike Wiese, Pierre Olivier Frappart, Ninel Azoitei, Karolin Walter, Volker Rasche, Li Hao, Johann Gout, Sebastian Wiese, André Lechel, Ewa K. Kaminska, Jeanette Scheible, Thomas Seufferlein, Peter Möller, Caterina Prelli-Bozzo, Thomas J. Ettrich
Publikováno v:
Cancer research. 81(7)
Pancreatic ductal adenocarcinoma (PDAC) still presents with a dismal prognosis despite intense research. Better understanding of cellular homeostasis could identify druggable targets to improve therapy. Here we propose RAD50-interacting protein 1 (RI
Autor:
R Koehntop, Thomas J. Ettrich, K Alexander, Johann Gout, L Perkhofer, Elodie Roger, Haenle Mm, Jeanette Scheible, M Mueller, Beutel Ak, T Seufferlein
Publikováno v:
DGVS Digital: BEST OF DGVS.